Conditions & Recovery · ScienceDaily — Cancer · June 5, 2026

Scientists discover why ozempic may not work for some people

Scientists have identified genetic variants that may make some people less responsive to GLP-1 drugs used to treat Type 2 diabetes. Roughly 10% of the population carries these variants, which appear to cause a mysterious form of "GLP-1 resistance." In several clinical trials, carriers were significantly less likely to reach healthy blood sugar targets while taking GLP-1 medications.

Originally published by ScienceDaily — Cancer. We curate and add context; they did the reporting.

Related learning